Lisa H Underhill Selected Research

eliglustat

1/2020	Real-world effectiveness of eliglustat in treatment-naïve and switch patients enrolled in the International Collaborative Gaucher Group Gaucher Registry.
1/2019	Long-term adverse event profile from four completed trials of oral eliglustat in adults with Gaucher disease type 1.
1/2019	Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1.
1/2018	Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1.
1/2018	A pooled analysis of adverse events in 393 adults with Gaucher disease type 1 from four clinical trials of oral eliglustat: Evaluation of frequency, timing, and duration.
12/2016	Stability is maintained in adults with Gaucher disease type 1 switched from velaglucerase alfa to eliglustat or imiglucerase: A sub-analysis of the eliglustat ENCORE trial.
9/2016	Clinical response to eliglustat in treatment-naïve patients with Gaucher disease type 1: Post-hoc comparison to imiglucerase-treated patients enrolled in the International Collaborative Gaucher Group Gaucher Registry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisa H Underhill Research Topics

Disease

7	Gaucher Disease (Gaucher's Disease) 01/2020 - 09/2016
1	Pain (Aches) 01/2018
1	Back Pain (Backache) 01/2018
1	Diarrhea 01/2018
1	Abdominal Pain (Pain, Abdominal) 01/2018
1	Fatigue 01/2018
1	Flatulence 01/2018
1	Headache (Headaches) 01/2018
1	Arthralgia (Joint Pain) 01/2018
1	Nausea 01/2018
1	Thrombocytopenia (Thrombopenia) 12/2016
1	Anemia 12/2016

Drug/Important Bio-Agent (IBA)

7	eliglustatIBA 01/2020 - 09/2016
3	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2019 - 09/2016
2	imiglucerase FDA Link 12/2016 - 09/2016
1	AcidsIBA 12/2016
1	GlucosidasesIBA 12/2016
1	Glucosylceramides (Glucocerebrosides)IBA 12/2016
1	EnzymesIBA 12/2016
1	Hemoglobins (Hemoglobin)IBA 09/2016

Therapy/Procedure

6	Therapeutics 01/2020 - 09/2016
2	Enzyme Replacement Therapy 01/2019 - 09/2016